3. “New studies indicate that
an implantable device is
more effective than drugs
— but the device costs
$20,000. What’s that going
to do to our bottom line?”
For a 25,000 employee
organization, proactively
addressing the impact of new
medical technologies can
save up to $10 million over
the next two to three years.
Ingenix Health Technology Pipeline™ consolidates
decision-critical information that would otherwise take
a large and highly-skilled research staff to assemble.
With Ingenix Health Technology Pipeline, investigating the
most cost-effective new drug or device just got a lot easier.
Even better, we can tell you where it is in the pipeline and
what it’s likely to do to your bottom line.
focused
Ingenix Health Technology Pipeline is a leading edge product
that identifies emerging technologies, provides clinical research,
and forecasts the actuarial impact on your bottom line.
Ingenix Health Technology Pipeline provides you with national
forecasts and gives you current information about new treatments,
new devices, changes in medical guidelines, new drugs, drugs losing
their patents, and drugs going over the counter. Actuarial assumptions
allow you to customize projections to your own specific business.
Ingenix Health Technology Pipeline combines the clinical
information in the pipeline with financial forecasts — so you can
anticipate your future medical expenses — and plan accordingly.
Ingenix Health Technology Pipeline helps you make more
proactive coverage decisions, refine your care management
strategies, and more accurately forecast you future costs.
Want to start planning instead of reacting?
For more information on Ingenix Health Technology Pipeline,
call (800) 765-6073 or email us at more@ingenix.com
or visit us on the web at www.reden-anders.com/htp
confident
Ingenix Health Technology
Pipeline helps to make policy
decisions that, for one mid-sized
health plan, delivered quality
outcomes for members and saved
$0.45 per member per month.
That equated to more than
$1 million in annual savings
on behalf of its customers.
Wouldn’t you rather manage emerging technologies —
from a strategic and financial perspective — proactively?
What if you could anticipate increased health care
costs associated with the advancements of new
health technologies?
proactive
Reden & Anders, Ltd.
An Company
